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. MD, FACC, WITH THE TECHNICAL
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Washington, D .C.
This study investigated the effect of intravenous cocaine
(0.5 to 2 mg/kg body weight) on the coronary circulation
and systemic hemodynamies in closed chest sedated dogs .
The role of alpha. and beta-adeenoceptor stimulation in
mediating these effects was aim investigated. Cocaine pro-
duced dose-dependent increases in mean arterial pressure
and rate-pressure product. Although the lower doses of
cocaine had no significant effect on the coronary ciccuia-
tion, the 2 mg/kg dose produced a 55 ± 1 .1% increase in
coronary vascular resistance (p < 0 .05 versus baseline) and
a 19 m 3% reduction in diametor of the left anterior
descending coronary artery (p < 0 .05 versus baseline) .
Despite these potentially deleterious effects on the coronary
circulation (occurring at a time of markedly increased
myocardial oxygen demand), the electrocardiogram did not
demonstrate ischemic changes and there was no myocardial
lactate production .
Cocaine-induced coronary vasoconstriction was shol-
tshed by pretreatment with the alpha-adrenoceptor
antag-
The incidence of cocaine abuse has reached epidemic pro-
portions in numerous communities throughout the United
States. It is estimated that 30 million Americans have used
cocaine at some time and 5 million use it regularly (1) . Over
the past 5 years, numerous cases of myocardial ischemia and
infarction have been reported to be associated with the
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nnist phentolamine, hut not by pretreatment with the
heta-adrenoceptor aatagontst propraoolol. The findings
that cocaine did not change systemic vascular resistance in
dogs without adrenergic blockade, reduced systemic vascu-
lar resistance in dogs after alpha-blockade (p < 0
.05) and
increased systemic vascular resistance in dogs after beta-
blockade (p = D.06) suggest that epinephrine (rather than
norepinephrine) is primarily responsible for the peripheral
vascular actions of maim .
Thus, in this canine preparation with normal coronary
arteries, cocaine produced vasocomtricioa
of both epicar-
dial and coronary resistance vessels that was not associated
with evidence of myocardial ischemia . The pharmacologic
mechanism for the effect of cocaine an the coronary circu-
lation is alpha-adrenoceptor stimulation,
whereas systemic
hemadynamic effects are mediated by combined alpha- and
beta-adrenoeeptor stimulation .
(! Am Call Cardiol 1990
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recreational use of cocaine
(2-16) . It has been postulated
that cocaine-induced myocardial ischemia
results from cor-
onary vasospasm or a marked imbalance between myocar-
dial oxygen supply and demand (2,3) ; however, few clinical
or experimental data exist in support of these
postulates . We
therefore investigated the effect of cocaine on the coronary
circulation (epicardial and coronary
resistance vessels) and
on systemic hemadynamics .
The lack of understanding of the mechanisms responsible
for cocaine-induced cardiovascular complications has se-
verely limited a rational approach
to prevention and treat-
ment of these serious problems . To clarify the pharmaco-
logic mechanism whereby cocaine produces its effects on the
coronary circulation and on
systemic hemodynamics, we
investigated the role of alpha- and beta-adrenoceptor stimu-
lation in mediating these actions
.
0735-IO97NO/53.50
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Methods
This study conformed to the guidelines specified in the
National Institutes of Health Guide for Care and Use of
Laboratory Animals and was approved by the Animal Care
and Use Committee of the Georgetown University School of
Medicine
.
Experimental preparation. Adult male mongrel dogs (25
to 30 kg) received the short-acting anesthetic thiopental
sodium (25 mg/kg body weight intravenously) and were
incubated with a cuffed endotracheal tube and ventilated
with a Harvard respirator (Harvard Instruments) . Adequacy
of ventilation was assessed by periodic arterial blood gas
determinations
; pH was maintained at 7 .40 ± 0 .05 . The
potent short-acting narcotic sufentanil was given as a bolus
injection (2 pg/kg intravenously) followed by a continuous
intravenous infusion (I pg/kg per h) to achieve a constant
level of sedation throughout the experiment . Pancuronium
bromide (0
.1 mg/kg intravenously) was given as needed to
provide continuous skeletal muscle relaxation
. A bipolar V J
chest lead (addressing the anterior wall of the left ventricle
supplied by the left anterior descending coronary artery) was
attached to provide electrocardiographic (ECG) and arrhyth-
mia monitoring.
Animals were then positioned supine on the catheteriza-
tion table and both femoral arteries and the right femoral
vein were cannulated percutaneously with introducer
sheaths. A 7F micromanometer-tipped pigtail catheter (mod-
el SPC474-A, Millar Instruments) was advanced under fluo-
roscopic guidance to the apex of the left ventricle to measure
left ventricular pressure and perform microsphere injections
.
A second micromanometer-tipped catheter (model MPCS00,
Millar Instruments) was placed in the aortic root for mea-
surement of aortic pressure
. The micromanometers were
driven with a direct current preamplifier (Gould Electronics)
and zero referenced and balanced at 38'C immediately
before each study
. The zero drift did not exceed 0 .5 mm Hg
during the course of any study
. The left main coronary artery
was intubated with a 6F Judkins catheter (type 3
.5 left) for
subsequent coronary angiography . A 7F thermodilution pul-
monary artery catheter (American Edwards Laboratories)
was advanced into the main pulmonary artery
. Cardiac
output was determined by the thermodilution technique with
use of a cardiac output computer (model 9520, American
Edwards Laboratories) and recorded as the average of three
determinations obtained with hand injections of saline solu-
tion (10 ml, 0° to 5°C)
. All tracings were recorded on an eight
channel recorder (model TA2000, Gould Electronics) for
subsequent analysis.
Study protocol
. After 20 to 30 min of stable hemodynam-
ics after instrumentation, baseline hemodynamic measure-
ments (heart rate, cardiac output and left ventricular and
aortic pressures), coronary angiography and myocardial
blood flow determinations (by microsphere injection) were
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performed . Dogs were assigned to receive one of three doses
of cocaine hydrochloride by intravenous bolus injection . The
first group of eight dogs received 2 mg/kg of cocaine .
Hemodynamic measurements and coronary angiography
were performed 2, 5, 10, 15, 30 and 60 min after cocaine
administration . Microsphere injections (to assess myocardial
blood flow) were performed 2, 5 and 10 min after cocaine
administration . In four of these eight dogs, a control study
was performed before cocaine administration to evaluate the
coronary angiographic and hemodynamic effects of repeated
contrast injections . This study was identical to the subse-
quent cocaine protocol except that a saline solution placebo
was administered instead of cocaine and microsphere injec-
tions were not performed . The subsequent responses to
cocaine in these four dogs were similar to those observed in
the other four dogs in this group . Two additional groups of
four dogs each were studied to determine the dose response
to cocaine . The study protocol was identical to that of the
group receiving 2 mg/kg of cocaine, except that cocaine
doses of either 0.5 or I mg/kg were administered .
To assess the role of alpha-ad
,erocepiors in mediating
the cardiovascular effects of cocaine,
a fourth group of six
dogs was pretreated with the alpha-adrenoceptor antagonist
phentalamine (2.5 mg/kg intravenously) 10 min before ad-
ministration of cocaine (2 mg/kg intravenously) . This dose
has been shown to fully antagonize the alpha-adrenoceptor-
mediated effects of norepinephrine (17).
Hemodynamic mea-
surements, coronary angiography and myocardial blood flow
determinations were performed 5 min after phentolamine
administration, and these values served as the precocaine
baseline data . After cocaine administration, hemodynamic
status and myocardial blood flow were determined and
coronary angiography was performed according to the pro-
tocol described for the first three groups .
The role of beta-adrenoceptors in mediating the cardio-
vascular effects of
cocaine was assessed in a final group of
six dogs pretreated with propranolol (0
.75 mg/kg intrave-
nously) 10 min before administration of cocaine (2 mg/kg) .
This dose of propmnolol has been shown to fully antagonize
the beta-adrenoceptor-mediated effects of isoproterenol
(IS). The remainder of the study protocol was otherwise
identical to the protocol in the group with alpha-
adrenoceptor blockade .
Hemodynamic data were used to derive the following
variables:
SV = (CO x 1,000)/HR, RPP = (HR x LVPSP)l
1,000 and SVR = ([MAP - CVPJ/CO) x 80, where SV is
stroke volume (mI/beat), CO is cardiac output (litersimin)
and HR is heart rate (beats/min)
; RPP is rate-pressure
product (beats/min x mm Hg x 10 -J ) and LVPSP is left
ventricular peak systolic pressure (mm Hg) ; SVR is systemic
vascular resistance (dyne .s-cms), MAP is mean arterial
pressure (mm Hg) and CVP is central venous pressure (mm
Hg).
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Myocardial blood flow determinations. Transmural myo-
cardial blood flow was determined using the colored micro-
sphere technique
(19) .
Approximately 5 to 8 x 10° color-
labeled 11 .9 ± 1 .9 µm polystyrene microspheres (yellow .
orange, red, green, blue or black, E-Z Trac, SRP) were
thoroughly mixed by vortex agitation to -
I min and then
hand-injected through the central lumen of the pigtail cath-
eter into the apex of the left ventricle. Microsphere injec-
tions into the left ventricular apex have been shown to
compare favorably with left initial injections (20). Reference
arterial samples were withdrawn from the femoral artery at a
constant rate (13 .9 ml/min) using a withdrawal pump (model
901, Harvard Instruments), beginning 5 s before microsphere
injection and continuing for 90 s after injection .
At the conclusion of each experiment, dogs were sacri-
ficed with an overdose of potassium chloride (40 mEq
intravenously), and a Iransmural sample of myocardium (2 to
4 g) was excised from the anterior wall of the left ventricle
supplied by the left anterior descending coronary artery .
Blood and tissue samples were processed with digestive
reagents by methods previously described (19). Final ali-
quots from the blood and tissue samples were counted with
a hemocytometer, and four to eight chambers were counted
for each sample .
Myocardial
blood flow (MBF fin mllmin
per gJ) I as
then
calculated by the following equation : MBF = (C m
x Q,)/
(C r x WT), where C m is the total number of microspheres in
the tissue sample, Q
r
is the rate of reference blood with-
drawn) (mtlmin), Cr is the total number of microspheres in
the reference blood sample and WT is the weight of the
tissue sample (in g).
Coronary vascular resistance (CVR) was
calculated as
CVR = MAP/MBF, where MAP is mean arterial pressure
(mm Hg) and MBF is myocardial blood flow (mI/min per g) .
Coronary angiography, This was always performed in a
30' right anterior oblique position using hand injections (3 to
5 ml) of nonionic contrast medium (iopamidol 76%, Squibb)
and recorded on cinefilm at 30 frames/s. Nonionic contrast
medium was chosen because it produces less alteration in
cardiovascular variables than ionic agents (21) .
Coronary
aagiograms were performed during brief periods (10 s) while
the respirator was not cycling . For subsequent quantitative
analysis, angiograms were projected on a viewing screen and
traced at end-diastole by an observer who had no knowledge
of the experimental intervention. The proximal 1 .5 cm of the
left anterior descending coronary artery was divided into
three 0 .5 cm segments, and the diameter at the midpoint of
each segment was measured using calipers
. The final diam-
eter of the proximal vessel was then taken as the mean of
these three segments and was corrected for image magnifi-
cation using the known diameter of the angiographic cathe-
ter
. Pincushion distortion was minimized by keeping the area
of interest within the central third of the image intensifier.
The maximal distortion within this field was determined by
KUHN ET AL .
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using standardized grids and was found lobe < 1% . Through-
out the experiment. care was taken to avoid changes in
animal or camera position that might affect image projection
or magnification .
Myocardial lactate determinations
. To assess whether
cocaine (2 mg/kg intravenously) results in metabolic changes
consistent with myocardial ischemia, myocardial lactate
extraction was determined in a separate group of three dogs .
The coronary and systemic hemodynamic effects of cocaine
in these dogs were similar to those observed in the other
group that received 2 mg/kg. The right internal jugular vein
was canculated percutaneously and a 7F multipurpose cath-
eter was advanced into the coronary sinus, with its tip
positioned in the great cardiac vein . Correct catheter place-
ment was confirmed by contrast injection and o-imetric
study of blood samples
. Lactate extraction was determined
at baseline and 5 min after cocaine administration by collect-
ing simultaneous blood samples from the ascending aorta
and the great cardiac vein. Serum lactate concentration was
determined spectrophotometrically with a Dupont AutoAn-
alyzer .
Percent lactate ettracfiort was calculated as : (I act,
-
Lact_) x 100 / Lact,. where Lact, is aortic lactate concen-
tration and Lact
r ..,
is great cardiac vein lactate concentra-
tion.
Serum cocaine levels . In five dogs from the group receiv-
ing 2 mg/kg cocaine, venous blood (10 ml) was drawn into
chilled Vacutainer tubes (Beckton-Dickinson) containing
sodium fluoride and calcium oxalate at 5, 10, 15
. 30 and 60
min after cocaine administration
. Serum concentrations of
cocaine were subsequently measured with gas chromatogra-
phy-mass spectroscopy using selected ion monitoring (22)
(American Medical Laboratories).
Statistical analysis
. Data are presented as mean values
SEM . Statistical analysis of the changes from the precocaine
baseline study to peak effects was performed using Student's
t test for paired samples (two-tailed)
. Analysis of variance
was used to assess differences between study groups . When
significant differences were found, a multiple comparisons
procedure (Tukey's test) was used to determine at which
time points the groups differed
. A linear regression analysis
was performed to assess the relation between cocaine dose
and several cardiovascular variables . A p value <0.05 was
considered significant .
Results
Effect of cocaine on systemic hemodynamics (Table f)
. The
hemodynamic effects of three doses of cocaine
(0.5, 1 and
2
In/kg
intravenously) are shown in Table 1
. Cocaine
(0.5 mgtkg) had minimal effects on hemodynamics except for
a small but statistically significant reduction in left ventric-
ular end-diastolic pressure and a borderline significant (p =
0 .07) increase in stroke volume, Cocaine (I mg/kg) produced
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Te6fe t . Bert of Intravenous Cocaine on Several Indexes of Cardiovasnr~r Function in 16 Dogs
'p < 0
.05 versus baseline values. Data are mean values 1 S EM. C O =cardiac mipul ; HR
„
heart rate ; LVEDP = lea ventlicutar end .diassolic pressure ;
MAP = mean arterial pressure ; SV = stroke volume ; SYR=sysoeraic vascular rtsistaena,
a significant increase in heart rate and a modest increase in
mean arterial pressure of borderline statistical significance
(p = 0.06) . The 2 mg/kg dose of cocaine resulted in pro-
nounced hemodynamic changes, including a significant
increase in heart rate, mean arterial pressure, left ventricular
end-diastolic pressure and cardiac output . The increase in
mean arterial pressure was associated with a comparable
increase in systolic (127 ± 6 to 199 ± 25 mm Hg, p < 0 .01)
and diastolic (88 ± 7 to 137 ± 13 mm Hg, p < 0.OOp
aortic pressures
. This pressor effect occurred in the absence
of any significant effect
of cocaine on systemic vascular
resistance.
Although the 0.5 mg/kg cocaine dose had no significant
effect on rate-pressure product, the I and 2 mg/kg doses
produced significant increases in this variable (Table 2),
with a maximal increase of 129 ± 51% observed 5
mm
after
the 2 mgkg dose
. Linear regression analysis confirmed a
direct correlation between cocaine dose and augmentation of
mead arterial pressure (r = 0 .84, p < 0,001) and rate .
pressure product (r = 0.58, p < 0.02). A trend toward a
dose-response relation for heart rate was also observed (r =
0.46, p = 0.07) .
The rime course of the cardiovascular
effects produced by
Table 2. Effect of Cocaine on Coronary Hemodynanucs in 16 U68s
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cocaine, (2 mg/kg intravenously) is illustrated in Figure
1 .
Hemodynamic changes occurred rapidly, with maximal ef-
fects observed approximately 5 min after drug administra-
tion . This was followed by a gradual return to baseline
values over I h .
Effect of cocaine on coronary hemodynamics . The effects
of cocaine (0
.5 to 2 mglkg intravenously) on myocardial
blood flow, coronary vascular resistance and rate-pressure
produce are shown in Table 2. Again, the most striking
effects were observed after the 2 mg/kg dose . Two minutes
after this dose, coronary vascular resistance increased 55
14% (p < 0 .415 versus baseline) despite a 50 ± 16% increase
in rate-pressure product (p < 0
.05 versus baseline). The two
lower doses of cocaine (0.5 and I mg/kg intravenously) also
resulted in an increase in coronary vascular resistance at
2 min, but these changes were of smaller magnitude and did
not reach statistical significance.
Five minutes after the 2 mg/kg dose of cocaine, coronary
vascular resistance returned to near baseline values in
association with further increases in rate-pressure product-
Five and 10 min after cocaine administration in the 1 mg/kg
group, coronary vascular resistance was significantly re-
duced from the precocaine baseline value,
'p < 005 versus baeebne values
. Data are mean values 0 SEM
. CVR = ca0nar9 vascular reslsmnce ; MOP = myocardial blood Bow; RPP = rate.pressure
product
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1 11007
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5 0.88 0
0.09 1 .28 20.13 1061 I6
10 1
.20 1
0.14 0.96 0 0.24 105 m 16
1 4
Baseline Ill 1 0.18 1 .00 10,17
11114
2 1 .07 0 0.30 1 .41 0 0.34 135 1 22'
5
1 .6600.10 0.6700.08' 123< 19
In 1 .02 t 0.37 0.67 2 0.17'
134
1
22
2 8 Baseline 1 .35 a 0.38
1 .06 1 0.17 96 x 7
2 1 .03 ! 0.29
1 .51
1
017'
158
t 36'
5
2.54 ± 0.97 1 .16 a 0.33
274-82'
10 2.05 0 0.68 3 .23 0 0.29 206'- 55'
Cocaine
nonc
angagl
No. of
Dogs
Expreimenlal
Condition
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lbeats/min)
MAP
ImtHe)
t
.VFDP
(mm NB)
CO
Ilaer4/mm)
SV
(.I/b1)
SYR
(dyncsmm s)
0.5 4 Baseline 89 o 7 101 x e
5.0
S 0
.9 4
.00 ± 0
.30 44 .9 t 3.4 2,028 t 293
Peak 87 '_ IS 101 9 15 ± 1 .0' 4 .74 t 0.60 52 .0 t 3.2 1,825 t 204
I 4 Baseline 86 t 14 110 t 9 4.3 t 9 3 .87 m 0.45 46
.0
0 4
.5 2,320
t
389
Peak 112 t 16' 121 t 12 4.3 ± 06 4 .83 ± 0.25
48 .5
0
3.9
1,9( t ± Lib
2 8 Baseline 80 *_ 9 104 ± 6 3.0 t 0.6 3 .66 ± 0.61 47
.0 ± 6.0
2,478 ± 331
Peak 116 t 15 - 156 t ]2' 8.601 .6' 6.06 1 1 .40' 48 .0 1 6.2
2.5160426
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Figure 1. Effect of cocaine (2 mgkg
intravenously) on heart rate . mean ar-
terial pressure (MAP), left ventricular
end-diastolic pressure (LVEDP) and
cardiac output. Eight dogs (filled cir-
cles) received cocaine ; four dogs (open
circles) received a saline solution pla-
echo. 'p < 0.05 versus baseline .
Effect of cocaine on coronary artery diameter (Fig. 2) .
Baseline diameter of the left anterior descending coronary
artery was 3 .4 ± 0 .3 mm for the group that received cocaine
and 3.1 ± 0 .2 mm for the control group (saline solution
placebo) . C .,caine resulted in a 19 ± 3% reduction in left
anterior descending coronary artery diameter (p < 0
.05
vesus baseline) 2 min after drug administration, with a
return to baseline dimension by 15 min
. This was in contrast
to the small increase in epicardiai vessel diameter observed
in the control group, probably resulting from contrast-
induced vasudilation. Cocaine-induced left anterior descend-
ing coronary artery narrowing was observed to be a diffuse
Figure 2. Effect of cocaine (2 mg/kg intravenously) on left anterior
descending (LAD) coronary artery diameter in eight dogs . The
control group (n = 4) (open circles) received a saline solution placebo
instead of cocaine (filled circles). 'p < 0.05 versus baseline
; e p <
0.05 cocaine versus control dogs
.
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phenomenon because focal vasospasm was not observed in
any experiment . Epicardial vasoconstriction occurred in
association with a significant increase in coronary vascular
resistance, despite a marked increase in rate-pre :sure prod-
uct. The two lower doses of cocaine (0 .5 and I mg/kg
intravenously) had no significant effect on the diameter of
the left anterior descending coronary artery .
Effect of cocaine on the ECG. No ischemic ECG changes
or ST segment shifts were observed in response to cocaine in
any of the dogs studied
. In addition, no significant ventric-
ular arrhyth^_as were seen .
Effect of cocaine on myocardial lactate extraction . Myo-
cardial lactate extraction was 63 ± 1% at baseline study and
55 ± 7% 5 min after intravenous administration of 2 mg/kg of
cocaine (p = NS). Net myocardial lactate production was
not observed in any of the dogs studied .
Serum cocaine levels . Mean serum concentrations of co-
caine obtained during a I h period after the 2 mglkg dose of
cocaine are shown in Figure 3 . The peak level obtained 5 min
after cocaine administration was 1,142 ± 115 nglml
. Serum
levels declined in an exponential fashion over the 60 min
period of measurement
; the serum half-life was 50 min .
Ef ects of -4drenergic Blockade
Alpha-adrr noeeptor blockade and coronary hemedyoamies
(Table 3). The effect of alpha-adrenoceptor blockade on
cocaine-induced changes in coronary hemodynamics
. epi-
cardial coronary artery diameter and rate-pressure product
are shown in Table 3
. Administration of phentolamine
(2
.5 mg/kg) produced significant increases in rate-pressure
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Figure 3 . Serum cocaine concentration over the course of 1 h after
a 2 mg/kg intravenous bolus ialection of cocaine ; the serum half-life
is 50 min .
product and myocardial blood flow compared with prephen-
tolamine baseline values . Subsequent administration of co-
caine (2 mg/kg intravenously) produced vasodilation in the
left anterior descending coronary artery (p < 0 .05 at 2 min)
and a decrease in coronary vascular resistance (p < 0 .05 at
10 min), but no significant changes in myocardial blood flow
or rate-pressure product .
When compared with findings in control dogs without
adrenergic blockade (Fig. 4), alpha-adrenaceptor blockade
dramatically altered the vasoconstriclive effect of cocaine
(2 mg/kg) on the coronary circulation (2 min after cocaine) .
Specifically, pretreatment with phentolamine abolished both
the cocaine-induced increase in coronary vascular resistance
and the reduction in left anterior descending artery diameter.
Be
? 60
W
m
40
20
4
4
U -20
-40
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RPP CVR LAD-DIAM
Figure 4. Effect of adrenoceptor blockade on cocaine-induced
(2 mg/kg intravenously) changes in late-pressure product (RPP),
coronary vascular resistance (CVR) and left anterior descending
coronary artery diameter (LAD-DIAM) . Data shown were obtained
2 min after cocaine administration to coincide with the time of peak
effect on the coronary vasculamre and represent mean percent
change (±SEM) from the postadrenoceptor blockade baseline .
Eight dogs received cocaine alone, six dogs were pretreated with
phentolamine (a black + Coc) and six dogs were pretreated with
propranolol (p black + Cue). 'p < 0.05 versus baseline ; #p < 0 .05
between groups.
In addition, this intervention prevented the increase in
rate-pressure product produced by cocaine, thereby greatly
limiting cocaine-induced increases in myocardial oxygen
demand.
Beta-adrenoceptor blockade and coronary hemodynamics
(Table 3). As expected, pretreatment with propranolol (0 .75
mg/kg) significantly reduced the rate-pressure product and
Table 3
. Effect of Adrenergic Receptor Blockade on Cocaine-Induced (2 mg/kg) Changes in Coronary Hemodynamics and Left Anterior
Descending (LAD) Coronary Artery Diameter
'p < 0 .05
versus baseline pro-adrenoceptor blockade ; 0p < 0 .05 versus baseline post-adrenoceptor blockade . Data are mean values ± SEM . Abbreviations
as in Table 2.
Pretreatment
No. of
Dogs
Experimental
Condition
MBF
ImVmin per g)
CVR
(eon Hgsml- '•m
img)
RPP
heats//in a mm Hg x 10')
LAD Diameter
(mm)
Phentolamine 6 Baseline 1 .03 0 0.06 1.0030 .14 112015 3 .3x0.2
(2.5 mg/kg) (pre-phentolamine)
(alpha-blockade) Baseline
(post-phentolamine)
Past cocme
1 .72 3 0.36" 0.87 174x17' 3 .230.2
2 min 1 .54 x 0.33 0.75 0
0 .16 192
0
22 3 .5 ± 0.20
5 min 1 .76 0 0.28 0 .61 3 0
.15 184,
-• 23
3
.3 x 0
.1
10 min 1 .87 0.20 0 .53 0.09t 184027 3.330 .2
Propranolol 6 Baseline 1
.01 ` 0.16 1 .18 *_ 0.17 124
0
12 3.5 0 0 .3
(0 .75 mg/kg) (pre-Propmnnlol)
(bem-blockade) Baseline
Ipost-propranololl
Post-cocaine
0.73 3 0.06" 1 .41 3 0.12' 89 0 7'
3.5
0
0 .3
2 min 62 x 0
.25 1 .94 128±IIt 3 .330 .2
5 min 1 .15 -_ 0
.220
1 .56 ± 0
.23 136 ± 200 3 .2 *- 0 .2
10 min 1.02 0 0 .16 1 .67 3
0.27
120 0 210
3 .4 0 0 .3
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Table 4. Effect of Adrenergic Receptor Blockade on Cocaine-Induced IS mg!kgl Changes in Systemic Hemodynamics
myocardial blood flow, with a concomitant increase in
coronary vascular resistance . No significant change in epi-
cardial coronary artery diameter was observed . Subsequent
administration of cocaine to these beta-blocked dogs re-
sulted in a significant increase in coronary vascular resis-
tance (p < 0.05 at 2 min) and a trend toward reduced
epicardial coronary artery diameter, despite significant in-
creases in rte-pressure product (p < 0.05 at 2, 5 and
10 min). A transient increase in myocardial blood flow was
also observed (p < 0.05, at 5 min).
When compared with findings in dogs without beta-
adrenergic blockade (2 min after cocaine administration),
prior beta-adrenoceptor blockade did not alter the increase
in rate-pressure product or coronary vascular resistance
produced by cocaine (Fig . 4) . Although the cocaine-induced
reduction in left anterior descending artery diameter was less
striking in dogs with beta-adrenergic blockade, this response
was not statistically different from that in dogs without
beta-adrenergic blockade .
Alpha-adrenoceptor blockade and hemodynamic response
(Table 4). Pretreatment with phentolamine (2 mg/kg) re-
sulted in a significant increase in heart rate as well as
significant reduction .  in mean arterial pressure, left ventric-
ular end-diastolic pressure and systemic vascular resistance .
Stroke volume and cardiac output were not significantly
affected. In contrast to the marked pressor effect of cocaine
(2 mg/kg) in dogs without alpha-adrenergic blockade, mean
arterial pressure was not significantly increased by cocaine
in these dogs with alpha-adrenergic blockade . Cocaine pro-
duced a significant reduction in systemic vascular resistance
in phentolamine-pretreated dogs, even though alpha-
adrenoceptor blockade alone had significantly reduced sys-
temic vascular resistance . In addition, alpha-adrnoceptor
blockade prevented the increase in heart rte normally
'p
< 0.05 versus baseline pre-adrenoceptor blockade, -p < 0.05 versus hemline post-adrenocepmr blockade . Data are mean values m SEM. Abbreviations
as in Table I .
observed with cocaine
; however, this effect may have been
related to the positive chronetropic effect of alpha-
adrenoceptor blockade itself, thereby blunting any addi-
tional cocaine-induced increase in heart rate . Similar to the
results observed in dogs without alpha-adrenergic blockade,
cocaine administration caused significant increases in left
ventricular end-diastolic pressure and cardiac output in dogs
pretreated with phentolamine . Although increased cardiac
output in dogs without alpha-adrenergic blockade was due to
a positive chronotropic effect of cocaine, the increase in
cardiac output in phentolamine-pretreated dogs was primar-
ily related to a reduction in systemic vascular resistance,
although small increases in heart rate, left ventricular end-
diastolic pressure (preload) and stroke volume also may
have contributed to this effect.
Betaadrenoceptor blockade and hemodynamie response
(Table 4) . As expected, beta-adrenoreceptor blockade with
propranolol resulted in a significant reduction in heart rate
.
Administration of cocaine (2 mglkg) to these dogs with
beta-adrenergic blockade resulted in significant increases in
heart rate, mean arterial pressure and left ventricular end-
diastolic pressure . These effects were not statistically dif-
ferent from those produced by the same dose of cocaine in
dogs without beta-adrenergic blockade . A trend toward
increased systemic vascular resistance was also observed in
this group (p = 0 .06) .
Discussion
These experiments demonstrate that doses of cocaine
ranging from 0.5 to 2 mglkg produce dose-dependant in-
creases in mean arterial pressure and rte-pressure product
.
More important, they demonstrate that although low doses
of cocaine (0,5 and I mg/kg) have minimal effect on the
Pretreatment
No, or
Dogs
Experimental
Condoms
HR
Ibeatslmlnl
MAP
/mm ligl
LVEDP
Imm Hgl
CO
(liters/minl
SV
babbeatl ldynrscm
`3
Phentolamine 6 Baseline 79 s 5 115 0 9 6.5 a 1 .3 4 .23 '_ 0.34 53.7 0 4 .5 2,166 x 237
(2.5 mglkg) (Pre-phemalamine)
lalphe-blockade)
Baseline (63 ^_ 23' 49 c 13' 2.3 0 1 .3' 5 .93 - 0.75 44 .7 0 5.4 1 .636 x !74-
(post phentolam en)
Peak value
after cocaine
174 - 19 97
1'-
7 _'I 6i 7.95 t I, lot 51 .5 5 1.0 1 .065 v 1933
Proprannlot
6
Baseline
44 0 9 100 . 5 i 11 - 1
. 306
0 0.15 47.1 x 4
.9
1 .941 1 92
(0 .75 mg(kgl Ipuopeopranolol)
(beta-blockade)
Baseline 69 7' 97-3 s,) c 15 3,490022 53 .4!5 .6 2209'_165
(post prepranolol)
Peak value 88 - 6* 1227 r 1'" 11 7
2,63
405 0 0U.35 51 .0 0 4.2 22.634 x 465
aaer eoemne
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coronary circulation, a 2 mg/kg dose results in significant
vasoconstriction of both epicardial and coronary resistance
vessels . Although these effects could result in an imbalance
in myocardial oxygen supply and demand, there was no
evidence for myocardial ischemia by ECG or by measure-
ment of myocardial lactate extraction. We also determined
that the pharmacologic mechanism responsible for cocaine-
induced coronary vasoconstriction is alpha-adrenoceptor
stimulation, whereas the peripheral vascular actions of co-
caine are mediated by a combination of alpha- and beta-
adrenoceptor stimulation .
Cocaine and systemic hemodynamics
. The findings that
cocaine produces increases in heart rate, mean arterial
pressure and rate-pressure product are consistent with prior
experimental (23,24) and clinical (25) reports. The pressor
effect of cocaine observed in dogs without adrenergic recep-
tor blockade was primarily due to its effect on increasing
cardiac output, as systemic vascular resistance was not
significantly increased . Because cocaine inhibits the re-
uptake of norepinephrine at sympathetic nerve terminals
(26), it might have been expected to increase systemic
vascular resistance through alpha-adrenoceptor-mediated
vasoconstriction . However, our results suggest that cocaine
stimulates both alpha- and beta-adrenoceptors in the periph-
eral vasculature, thereby producing a balance between pe-
ripheral vasoconstriction and vasodilation . This view is
supported by our finding that cocaine administration did not
significantly change systemic vascular resistance in dogs
without adrenergic receptor blockade but did produce a
significant reduction in systemic vascular resistance in the
presence of alpha-blockade and resulted in a trend toward
increased systemic vascular resistance in the presence of
beta-blockade (p = 0.06) .
The systemic vascular resistance response to cocaine in
dogs without adrenergic receptor blockade, and dogs with
alpha- or beta-adrenergic blockade is best explained by the
predominant action of epinephrine, a potent stimulator of
beta
s-adrenoceptors (in addition to alpha- and beta l -
adrcnoceptors). Indeed, Chiueh and Kopin (27) demon-
strated that cocaine results in a fivefold increase in the
adrenal release of epinephrine in the conscious rat . Thus, the
cocaine-induced decrease in systemic vascular resistance in
dogs with alpha-adrenergic blockade is due to the predomi-
nant peripheral vasodilating effect of betas-adrenoceptor
stimulation by epinephrine, and the cocaine-induced in-
crease in systemic vascular resistance observed in dogs with
beta-blockade is due to predominant alpha s -mediated pe-
ripheral vasoconstriction in the setting of beta2-adrenoceptor
blockade by propranolol . Although catecholamine levels
were not measured in our study, the hemodynamic findings
strongly support a role for cocaine-induced epinephrine
release . These findings cannot be explained by the action of
norepinephrine alone because norepinephrine has minimal
JACC Vol . 16. No. 6
November 15. 19sn:14b1-91
activity at beta= adrenoceptors, which predominate in the
peripheral vasculature .
Cocaine and the coronary circulation . We showed that
cocaine produces a marked increase in rate-pressure prod-
uct, a major determinant of myocardial oxygen demand
(28) .
Such increases in myocardial oxygen demand normally lead
to metabolically induced coronary vasodilation (29) with a
concomitant decrease in coronary vascular resistance . In
contrast, cocaine induces transient vasoconstriction of both
coronary epicardial and resistance vessels at a time when
myocardial oxygen demand is greatly increased . Although
these results suggest that cocaine leads to an imbalance in
myocardial oxygen supply and demand, myocardial ische-
mia was not evident from the ECG tracings and myocardial
lactate production was not observed (5 min after cocaine
administration). Although we cannot exclude the possibility
that transient lactate production occurred 2 min after co-
caine administration (at the time of peak increase in coro-
nary vascular resistance), no lactate production was identi-
fied at the time of significant epicardial coronary
vasoconstriction and peak increase in myocardial oxygen
demand (5 min after cocaine) . Thus, in this animal model
with normal coronary arteries, cocaine produces coronary
vasoconstriction that does not appear to be of sufficient
magnitude or duration to cause myocardial ischemia.
Ourfindings regarding the effect of cocaine on coronary
vascular resistance are consistent with studies in dogs (30)
and humans (31) . In the study of Wilkerson (30), as in our
own, the administration of I mg/kg of cocaine increased
coronary vascular resistance, although not significantly .
Lange et al. (31) administered 2 mgkg of cocaine intrana-
sally and demonstrated a 33 ± 29% increase in coronary
vascular resistance, which is similar to the 55 c 14%
increase in coronary vascular resistance observed in our
study after a 2 mg/kg intravenous dose of cocaine .
Our finding ofcocaine-induced epicardial coronary vaso-
constriction is also consistent with human data obtained by
Lange et al. (31) . They demonstrated a 10 ± 5% reduction in
the diameter of the proximal left anterior descending coro-
nary artery in response to a 2 mg/kg intranasal dose of
cocaine . In contrast, Bedottc et al . (32) found no constrictive
effect of cocaine on epicardial coronary arteries in a canine
model. Their finding may have been due to the dosing
regimen employed (a constant infusion of 0.5 mg/kg per
min), which would not be expected to produce the same rate
of rise in cocaine serum concentration as that achieved with
an intravenous bolus injection. In addition, this constant
infusion may have caused tachyphylaxis, thereby reducing
the effect of cocaine on the coronary arteries (25) .
Although diffuse epicardial coronary vasoconstriction
was noted in our experiments with the 2 mg/kg dose of
cocaine, focal vasospasm was never observed . Several in-
vestigators (2,3,5-7)
have postulated that coronary vaso-
spasm may be responsible for cocaine-induced ischemic
JACC Vol. 15, Nn. 6
November It, 1990 :1481-91
events especially in patients with normal or minimally dis-
eased coronary arteries
; however, only two cases of angio-
graphically documented coronary artery spasm have been
reported (7,8) . In both cases, spasm was not documented
until several days after admission and last presumed cocaine
use . The substantial delay between cocaine use and docu-
mented coronary spasm casts doubt on a causal relation
between these events . Furthermore, ergonovine challenge
has yielded negative results in all cases in which it has been
performed (2-7) . Although it is difficult to extrapolate from a
relatively small number of animals, our results combined
with the absence of convincing clinical reports suggest that
cocaine-induced coronary vasospasm is not a common
event
.
Mechanism of cocaine-induced coronary vasoconstriction.
Cocaine is known to inhibit the uptake of norepinephrine
into postganglionic sympathetic nerve endings (26) and may
release stored norepinephrine from sympathetic nerve ter-
minals (33). In addition, cocaine stimulates catecholamine
release from the adrenal medulla (27). Kopia et al
. (34)
demonstrated that alpha,- and alpha, adrenoceptors are
present on coronary epicardial and resistance vessels in dogs
and both subserve coronary vasoconstriction. Thus . cocaine
may cause coronary vasoconstriction by means of catechola-
mine-mediated stimulation of alpha
s- and alpha,-adrenocep-
tors . Our finding that the nonselective alpha-adrenoceptor
antagonist phentolamine abolishes the coronary vasocon-
strictive effects of cocaine supports the hypothesis that these
effects are mediated by alpha-adrere gic receptor stimula-
tion. This hypothesis is also supported by human data from
fange et al. (31),
who demonstrated that cocaine-induced
coronary epicardial and resistance vessel vasoconstriction
was abolished by alpha-blockade with phentolamine .
In contrast to the effects of alpha-adrenoceptor blockade,
the nonselective beta-adrenoceptor antagonist propranolol
did not significantly alter cocaine-induced coronary vaso-
constriction. Because beta-adrenoceptor stimulation pro-
duces coronary vasodilation, beta-adrenoceptor blockade
might have been expected to potentiate the coronary vaso-
constrictive effects of cocaine by resulting in unopposed
alpha-adrenoceptor-mediated coronary vasoconstriction
.
Indeed, this theoretical concern led Olson et al
. (35) to
suggest that these agents should not be employed in the
treatment of cocaine-induced cardiovascular complications
.
Our finding that beta-adrenoceptor blockade did not
potentiate the coronary vasoconstrictive effects of cocaine
may be related to the presence of presynaptic sympathetic
beta2-adrenoceptors
. Presynaptic sympathetic nerve termi-
nals contain beta,-adrenoceptors that promote the release of
norepinephrine (36). Thus, propranolol may reduce neural
norepinephrine release, thereby reducing the extent of cor-
onary vasoconstriction that would otherwise be produced by
cocaine in the setting of unopposed alpha-adrenoceptor
stimulation. A second possibility that may explain why
KUHN ET AL .
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beta-adrenorecetior blcckade did not potentiate the coro-
nary vasoconstrictive effect of cocaine is that adequate
beta-blockade was not achieved with the propranolol dose
administered . For example, a small but significant increase
in heart rate wrc observed in dogs after beta-blockade in
response to cocaine (Table 4) . However, we believe beta-
blockade was a( equate for several reasons . First, propran-
olol (0 .75 mgtkgl resulted in changes consistent with beia-
blockade . including a significant decrease in heart rate,
rate-pressure product and myocardial blood flow and a
significant increase in coronary vascular resistance (Tables 3
and 4). Second . prior work from our laboratory (18) demon-
strated that this dose of propranolol abolishes the chrono-
tropic response to intravenous isoproterenol in dogs . Third,
the increase in lira t rate observed after cocaine administra-
tion in dogs after beta-blockade may be related to an
anticholinergic effect of cocaine (37).
Potential study limitations- The potential limitations of
our study incluce Thos_ inherent in any animal model of
human disease . Ir. is passible that a species difference in
vasoreactivity to cocaine may exist . The relative concentra-
tion and physiologic importance of adrenergic receptors may
be different in dogs ana humans. In addition, this study was
performed in dps with normal nonatherosclerotic coronary
arteries . Shimokawa et al. (38) suggested that coronary
atherosclerosis is a major predisposing factor for coronary
spasm . Thus, it is possible !bat the presence of atheroscle-
is with concomitant loss of endothelial-derived relaxing
factors may potentiate the effects of cocaine, although
preliminary data from our laboratory (59) suggest that endo-
thelial injury doe not potentiate cocaine-induced coronary
vasoconstriction.
Our model map not accurately simulate the dosing regi-
mens employed recreationally
. The lower doses (0 .5 and
I mg/kg) used in this study were similar to those reported by
Javaid et al. (40) to reproduce the psychotropic effects of
recreational cocaine closes in human volunteers
. The serum
cocaine levels obtained with the 2 mg/kgdose are higher than
those reported ba Javaid et al . (40) but are similar to those
reported in several postmortem studies (41-43) of cocaine-
related deaths. Iii addition, use of a single intravenous dose
may not accurately reproduce the cardiovascular effects
of
different patterns of cocaine use, in particular, the common
practice of repeated dosing or "hinging ."
Our studies were performed
in sufentanil-sedated dogs .
Anesthetics are known to blunt cardiovascular reflexes,
which may confound experimental results (44). In a recent
study Wilkerson (23) found that pentobarbital anesthesia
blunted the cardiovascular response to cocaine (I mg/kg
intravenously) and concluded that a conscious animal is the
only appropriate model in which to study the cardiovascular
effects of cscaire. Pitts et al. (45) also showed that pento-
barbital blunts the effects of cocaine
; however, in their
study, urethane-anesthetized animals had hemodynamic re-
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spouses to cocaine similar to those OF animals in the con-
scious state. Thus, the confounding effects of pentobarbital
anesthesia do not necessarily extend to all anesthetic agents .
Indeed, the increase in heart rate and blood pressure pro-
duced by cocaine (2 mg/kg) in our sufentanil-sedated dogs
was very similar to that observed by Wilkerson (23) in
conscious dogs, suggesting that our anesthetic regimen did
not greatly alter the cardiovascular responses to cocaine.
Clinical implications. This study demonstrates that co-
caine produces vasoconstriction of both coronary epicardial
and resistance vessels at a time when heart rate and systolic
blood pressure are markedly increased, but these effects are
not associated with myocardial ischemia in this animal
model . However, we cannot exclude the possibility that
cocaine-induced coronary vasoconstriction may result in
myocardial ischemia in patients who have atherosclerotic
coronary artery disease or who are concomitantly using
other drugs with potent coronary vasoconstrictioe proper-
ties, such as nicotine
(46) and ethanol (47).
Therapy of cocaine-induced myocardial ischemia and
infarction has been largely empiric
. Various agents have
been employed despite a lack of experimental evidence to
support their use (48). Our study provides a more rational
basis for treatment . The finding that alpha-adrenoceptor
blockade abolishes the coronary vasoconstictive effects of
cocaine suggests that alpha-adrenoceptor antagonists may
be useful in the treatment of cocaine-induced myocardial
ischemia and infarction. To be clinically effective these
agents should possess both alphar - and
alpha,-
a^tageaart
properties because both receptor subtypes are known to
subserve corona, - ssoconstriction
. In addition, our study
demonstrates that the beta-blocker propranolol does not
potentiate the vasoconstrictive effects of
cocaine on the
coronary circulation . Although this suggests that proprano-
lol need not be omitted from the treatment of cocaine-
induced hypertension or supraventricular tachycardia, hu-
man studies are warranted to prove the safety of this
approach.
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